Certain Shares of Eurocine Vaccines AB (publ) are subject to a Lock-Up Agreement Ending on 15-FEB-2024. These Shares will be under lockup for 183 days starting from 16-AUG-2023 to 15-FEB-2024.

Details:
Eurocine Vaccine's main owner Flerie Invest AB has, with customary exceptions vis-à-vis Markets & Corporate Law Nordic AB, undertaken not to sell existing shares for a period of six months from the publication of the Rights Issue (so-called lock-up). The lock-up agreement thus covers 100 percent of the shareholding before the Rights Issue. Existing shareholding during lock-up corresponds to approximately 28.7 percent of the total number of shares before the Rights Issue.